In Stat3-silenced cardiomyocytes, the PGE2-mediated protein synthesis was dramatically inhibited [57], suggesting that activation of Stat3 works downstream of PGE2-EP4-ERK1/2-mediated cardiac hypertrophy in vitro. The gene discussed is MAPK3; the disease is cardiac hypertrophy.